RYVU revenue breakdown overview

RYVU revenue for the last year amounted to 102.00 M PLN, the most of which — 77.97 M PLN — came from its highest performing source at the moment, Novel Small Molecule Therapies, the year earlier bringing 46.86 M PLN. The greatest contribution to the revenue figure was made by European Union Countries — last year it brought RYVU 69.33 M PLN, and the year before that — 41.66 M PLN.